Publisher
Springer International Publishing
Reference48 articles.
1. Adamson DJ, Dawson AA, Bennett B et al (1995) p53 mutation in the myelodysplastic syndromes. Br J Haematol 89:61–66
2. Bartram CR (1992) Molecular genetic aspects of myelodysplastic syndromes. Hematol Oncol Clin North Am 6:557–570
3. Bernstein C, Nfonsam V, Prasad AR, Bernstein H (2013) Epigenetic field defects in progression to cancer. World J Gastrointest Oncol 5:43–49
4. Carey N (2011) The epigenetics revolution. Icon Books, London, pp 205–232
5. Chang S, Yim S, Park H (2019) The cancer driver genes IDH1/2, JARID1C/KDM5C, and UTX/KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. Exp Mol Med 51:1–17